https://www.selleckchem.com/pr....oducts/Temsirolimus.
Aims To elucidate the impact of arsenic on progression and prognosis of bladder cancer. Patients methods Total arsenic in 145 tumors (80 non-muscle-invasive [NMIBC] and 65 muscle-invasive bladder cancer [MIBC]) was measured and associated with Ki67 expression, tumor-clinicopathological parameters and patient outcome. Results Tumor arsenic concentration was higher in exposed than unexposed patients (256 μg/kg vs 77 μg/kg; p 100 μg/kg) and Ki67 overexpression was established as predictors for recurrence (hazard ratio [HR] 4.68;
Like
Comment
Share
